PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Sagefrog Marketing Group, LLC

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

ImpactRx Releases 2010 Oncology Promotion Report - ImpactRx measures sales and marketing effectiveness in oncology offices
ImpactRx Releases 2010 Oncology Promotion Report


NewswireToday - /newswire/ - Mount Laurel, NJ, United States, 2011/02/02 - ImpactRx measures sales and marketing effectiveness in oncology offices.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


ImpactRx, a pioneer in tracking and evaluating pharmaceutical promotion on the prescribing behavior of physicians, completed its annual review of the detailing efforts of pharmaceutical/biotech sales representatives in oncology offices. The results have just been published in the January 2011 edition of Oncology Business Review.

ImpactRx’s mobile pharmaceutical market research system offers a longitudinal network of 475 oncologists who use iPhone technology and proprietary software to provide real-time data about sales representative promotion, meeting and event participation and patient treatment options. This year the data was supplemented with research into physicians’ online behavior provided through a joint offering ImpactRx has with comScore, a global leader in measuring digital traffic and readership. The result is a unique view of the promotional landscape in the fast-paced and ever-changing oncology market, helping pharmaceutical companies make the most of every minute with key physicians.

According to Richard Altus, President and CEO of ImpactRx, “Given the recent changes in the pharmaceutical and biotech industries, face time with oncologists is more valuable than ever. This data helps refine brand and targeting strategies to ensure that the right message gets to the right physicians, providing an optimized and powerful marketing strategy.”

Key data highlighted in the article includes:

•Share of Attention – Sales Representative Oncology Product Details 2006-2010;
•Top 25 Products Detailed by Sales Representatives 2009/2010;
•Oncology Sales Force Top Tier Rating 2010;
•Reach of Healthcare Websites (Jan – Sept 2010);
•Average Number of Visits per Month (Jan – Sept 2010).

About ImpactRx
Founded in 2000 and headquartered in Mount Laurel, NJ, ImpactRx’s longitudinal panel of high prescribing, smart phone-connected physicians is the exclusive source of continuously captured promotion and treatment data. Through its proprietary methodology, the Company captures annually one million details and three million treatment decisions, fueling its unique industry database. ImpactRx ( leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: Sagefrog Marketing Group, LLC


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

ImpactRx Releases 2010 Oncology Promotion Report

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Stacy Roberets - 
215-230-9024 jennifera[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sagefrog Marketing Group, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From Sagefrog Marketing Group, LLC / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe
BTG and Mirada Medical Announce CE Mark Certification for Simplicit90Y Dosimetry Software in Europe
FDA Grants Priority Review to Genentech’s Lucentis® (Ranibizumab Injection) Supplemental Biologics License Application
Genentech’s TECENTRIQ® (Atezolizumab) Shows Significant Survival Advantage Compared to Chemotherapy
Greenphire Continues Commitment to Clinical Research Site Sustainability and Innovation at Global Site Solutions Summit
Frost & Sullivan Highlights argenx for Enhancing the Therapeutic Qualities of Human Antibodies with its Proprietary Antibody Discovery Platform, SIMPL
FDA Grants Breakthrough Therapy Designation for Genentech’s Actemra® (Tocilizumab) in Giant Cell Arteritis, a Form of Vasculitis
MDxHealth Announces Agreement with SouthGenetics for Distribution of SelectMDx in Central/South America
BD and Apax Partners Announce Closing of Joint Venture to Launch Global Respiratory Business
Exosome Diagnostics Enters Agreement with Amgen
Sartorius Stedim Biotech Launches Two Single-use Sartocon® Loop Assemblies with Integrated Polyethersulfone (PESU) Membrane
BD Expands Efforts to Combat Antimicrobial Resistance with New Automated ID/AST System

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business



Visit  MagLar, Inc.

  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (